JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimmerman, B. G.
Right arrow Articles by Kraft, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmerman, B. G.
Right arrow Articles by Kraft, E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 187, Issue 2, 315-323, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF THE PROSTAGLANDIN SYNTHESIS INHIBITORS INDOMETHACIN AND EICOSA-5,8,1l,14-TETRAYNOIC ACID ON ADRENERGIC RESPONSES IN DOG CUTANEOUS VASCULATURE

B. G. Zimmerman 1, M. J. Ryan 1, S. Gomer 1, and E. Kraft 1

1 Department of Pharmacology, University of Minnesota,Minneapolis,Minnesota

The present study was carried out to determine the effect of the prostaglandin synthesis inhibitors indomethacin and eicosa-5,8,11,14-tetraynoic acid on adrenergic responses in the dog paw perfused at constant blood flow. Low-dose intra-arterial infusions of indomethacin, 3x10-6 M, and eicosa-5,8,11,14-tetraynoic acid, 1.5 to 3 x 10-5 M, into the paw had no significant effect on responses to norepinephrine injected intra-arterially or adrenergic nerve stimulation. Higher dose infusions of indomethacin, 6x10-6 M, and eicosa-5,8,11,14-tetraynoic acid, 3 to 6x10-5 M, were effective in potentiating the responses to both norepinephmrine and adrenergic nerve stimulation. There was also a tendency for vasconstriction to occur in the paw after administration of the inhibitors as reflected by a gradual increase in perfusion pressure during the course of these experiments. The adrenergic potentiating effect is not attributable to a blockade of adrenergic uptake by the prostaglandin synthesis inhibitors since in the concentrations employed there was no effect of these agents on the uptake of 3H-norepinephrine by vascular segments in vitro. Infusion of a low dose of prostaglandin E2 (110 mµg/min) depressed the responses to both norepinephrine and nerve stimulation. These data are consistent with the postulate that an E prostaglandin is synthesized and released in the cutaneous vasculature, and the released prostaglandin antagonizes the vasoconstrictor effect of norepinephrine. When this effect is blocked by the inhibitors, potentiation of the adrenergic responses results.

Submitted on December 29, 1972
Accepted on July 12, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.